NP Rank:
Type 2 diabetes drugs: risks w/o benefit
http://www.for-diabetes.com/type-2-diabetes-drugs-risks-wo-benefit
Yet another study, this one conducted in the U.K, has shown that the oral drugs typically prescribed for people with type 2 diabetes are killing some of them; and many more have suffered heart attacks and congestive heart failure while on the drugs. Ironically, these are the very conditions that the drugs are intended to prevent. The British Medical Journal recently published findings from a 15-year database of more than 91,000 people with type 2 diabetes. The drugs they were taking—Avandia, Actos, Glucophage, and Amaryl—will be familiar to Americans. This is the eleventh published study to acknowledge the fact that oral hypoglycemic drugs are associated with an increased risk of serious harms. This one shows that some are riskier than others.
Read More: http://www.for-diabetes.com/type-2-diabetes-drugs-risks-wo-benefit


Most RecentMost Recommended Comments (0)